Status:
COMPLETED
The Value of PET-CT in Pleural Effusions
Lead Sponsor:
Naestved Hospital
Conditions:
Pleural Effusion, Malignant
Eligibility:
All Genders
16+ years
Brief Summary
The investigators aim is to asses the diagnostic power of 18F-FDG PET-CT in discriminating malignant from nonmalignant causes in patients with a recurrent unilateral pleural effusion of unknown origin...
Detailed Description
The investigators follow the STARD 2015 guideline for reporting diagnostic accuracy studies. The investigators will review the hospital's administrative database of patients who underwent a thoracoce...
Eligibility Criteria
Inclusion
- Thoracocentesis
- Chest X-ray
- CT scanning
- PET-CT scanning
Exclusion
- Missing data
- Lung cancer
- Thoracic malignancies
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2019
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT03272997
Start Date
October 1 2017
End Date
January 30 2019
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naestved Hospital
Næstved, Denmark, 4700